Want to join the conversation?
Medical device maker $BDX's 3Q16 organic revenue grew 4% versus 3Q15. BD Medical segment revenue grew 3% due to growth in Medication Management Solutions and Diabetes Care Units. BD Life Sciences revenue grew 6%, mainly driven by growth in the Pre-Analytical Systems & Diagnostics Systems unit.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!